Voya SmallCap Opportunities Portfolio | PORTFOLIO OF INVESTMENTS |
as of March 31, 2023 (Unaudited) |
Shares | Value | Percentage of Net Assets | |||
COMMON STOCK: 95.7% | |||||
Consumer Discretionary: 10.3% | |||||
14,234 | Churchill Downs, Inc. | $ | 3,658,850 | 1.9 | |
35,190 | (1) | Dave & Buster's Entertainment, Inc. | 1,294,640 | 0.7 | |
17,574 | (1) | Five Below, Inc. | 3,619,717 | 1.9 | |
24,496 | (1) | Planet Fitness, Inc. | 1,902,604 | 1.0 | |
57,306 | (1),(2) | Revolve Group, Inc. | 1,507,148 | 0.8 | |
20,650 | (1) | Skyline Champion Corp. | 1,553,499 | 0.8 | |
29,629 | Strategic Education, Inc. | 2,661,573 | 1.4 | ||
18,847 | Texas Roadhouse, Inc. | 2,036,607 | 1.0 | ||
51,125 | (1) | Xponential Fitness, Inc. | 1,553,689 | 0.8 | |
19,788,327 | 10.3 | ||||
Consumer Staples: 1.2% | |||||
25,428 | (1) | Celsius Holdings, Inc. | 2,363,278 | 1.2 | |
Energy: 4.8% | |||||
303,334 | (1) | Helix Energy Solutions Group, Inc. | 2,347,805 | 1.2 | |
57,487 | Matador Resources Co. | 2,739,256 | 1.4 | ||
90,866 | Northern Oil and Gas, Inc. | 2,757,783 | 1.5 | ||
119,924 | Patterson-UTI Energy, Inc. | 1,403,111 | 0.7 | ||
9,247,955 | 4.8 | ||||
Financials: 5.1% | |||||
27,332 | (1) | Focus Financial Partners, Inc. | 1,417,711 | 0.7 | |
37,754 | (2) | HCI Group, Inc. | 2,023,614 | 1.1 | |
79,534 | (1) | I3 Verticals, Inc. | 1,950,969 | 1.0 | |
7,490 | Kinsale Capital Group, Inc. | 2,248,124 | 1.2 | ||
38,545 | (1) | Palomar Holdings, Inc. | 2,127,684 | 1.1 | |
9,768,102 | 5.1 | ||||
Health Care: 23.5% | |||||
24,876 | (1) | Acadia Pharmaceuticals, Inc. | 468,166 | 0.2 | |
27,136 | (1) | Alkermes PLC | 764,964 | 0.4 | |
38,290 | (1) | Amicus Therapeutics, Inc. | 424,636 | 0.2 | |
14,469 | (1) | Apellis Pharmaceuticals, Inc. | 954,375 | 0.5 | |
16,797 | (1) | Arrowhead Pharmaceuticals, Inc. | 426,644 | 0.2 | |
8,221 | (1) | Arvinas, Inc. | 224,598 | 0.1 | |
48,921 | (1) | Axonics, Inc. | 2,669,130 | 1.4 | |
8,809 | (1),(2) | Beam Therapeutics, Inc. | 269,732 | 0.1 | |
9,278 | (1) | Blueprint Medicines Corp. | 417,417 | 0.2 | |
10,013 | (1) | Charles River Laboratories International, Inc. | 2,020,824 | 1.0 | |
14,251 | (1) | Corcept Therapeutics, Inc. | 308,677 | 0.2 | |
11,021 | (1) | Cytokinetics, Inc. | 387,829 | 0.2 | |
13,862 | (1) | Denali Therapeutics, Inc. | 319,380 | 0.2 | |
31,531 | Ensign Group, Inc. | 3,012,472 | 1.6 | ||
43,093 | (1) | Establishment Labs Holdings, Inc. | 2,919,120 | 1.5 | |
110,049 | (1) | Evolent Health, Inc. | 3,571,090 | 1.9 | |
21,024 | (1) | Halozyme Therapeutics, Inc. | 802,906 | 0.4 | |
11,036 | (1) | ICON PLC | 2,357,179 | 1.2 | |
20,205 | (1) | Insmed, Inc. | 344,495 | 0.2 | |
13,958 | (1) | Inspire Medical Systems, Inc. | 3,267,149 | 1.7 | |
7,215 | (1) | Intellia Therapeutics, Inc. | 268,903 | 0.1 | |
15,245 | (1) | Intra-Cellular Therapies, Inc. | 825,517 | 0.4 | |
4,245 | (1) | Karuna Therapeutics, Inc. | 771,062 | 0.4 | |
18,762 | (1) | Lantheus Holdings, Inc. | 1,548,991 | 0.8 | |
20,264 | (1) | ModivCare, Inc. | 1,703,797 | 0.9 | |
42,816 | (1) | Natera, Inc. | 2,377,144 | 1.2 | |
60,318 | (1) | Option Care Health, Inc. | 1,916,303 | 1.0 | |
16,012 | (1) | Penumbra, Inc. | 4,462,384 | 2.3 | |
45,569 | (1) | Progyny, Inc. | 1,463,676 | 0.8 | |
27,274 | (1) | QuidelOrtho Corp. | 2,429,841 | 1.3 | |
116,881 | (1),(2) | R1 RCM, Inc. | 1,753,215 | 0.9 | |
45,451,616 | 23.5 | ||||
Industrials: 28.0% | |||||
16,459 | (2) | Advanced Drainage Systems, Inc. | 1,386,012 | 0.7 | |
14,784 | ArcBest Corp. | 1,366,337 | 0.7 | ||
123,039 | (1) | Array Technologies, Inc. | 2,692,093 | 1.4 | |
10,838 | (1) | Axon Enterprise, Inc. | 2,436,924 | 1.3 | |
119,327 | (1) | Bloom Energy Corp. | 2,378,187 | 1.2 | |
9,427 | (1) | CACI International, Inc. | 2,793,032 | 1.4 | |
19,396 | (1) | Casella Waste Systems, Inc. | 1,603,273 | 0.8 | |
18,755 | (1) | Chart Industries, Inc. | 2,351,877 | 1.2 | |
21,674 | (1) | Clean Harbors, Inc. | 3,089,846 | 1.6 | |
90,686 | (1) | Construction Partners, Inc. | 2,443,081 | 1.3 | |
49,668 | (1) | Driven Brands Holdings, Inc. | 1,505,437 | 0.8 | |
15,072 | (1) | ExlService Holdings, Inc. | 2,439,102 | 1.3 | |
13,383 | Exponent, Inc. | 1,334,151 | 0.7 | ||
85,298 | Flowserve Corp. | 2,900,132 | 1.5 | ||
113,608 | FTAI Aviation Ltd. | 3,176,480 | 1.6 | ||
27,601 | (1) | Kirby Corp. | 1,923,790 | 1.0 | |
72,979 | Marten Transport Ltd. | 1,528,910 | 0.8 | ||
49,832 | MAXIMUS, Inc. | 3,921,778 | 2.0 | ||
13,588 | (1) | NV5 Global, Inc. | 1,412,744 | 0.7 | |
8,625 | (1) | Saia, Inc. | 2,346,690 | 1.2 | |
44,794 | (1) | Sterling Infrastructure, Inc. | 1,696,797 | 0.9 | |
40,116 | (1) | WillScot Mobile Mini Holdings Corp. | 1,880,638 | 1.0 | |
59,527 | (1) | WNS Holdings Ltd. ADR | 5,546,131 | 2.9 | |
54,153,442 | 28.0 | ||||
Information Technology: 19.5% | |||||
11,259 | (1) | Axcelis Technologies, Inc. | 1,500,262 | 0.8 | |
34,584 | (1) | Blackline, Inc. | 2,322,316 | 1.2 | |
66,993 | (1) | Cohu, Inc. | 2,571,861 | 1.3 | |
15,443 | (1) | CyberArk Software Ltd. | 2,285,255 | 1.2 | |
44,336 | (1) | Five9, Inc. | 3,205,049 | 1.7 | |
24,436 | (1) | Guidewire Software, Inc. | 2,004,974 | 1.0 | |
183,612 | (1) | Harmonic, Inc. | 2,678,899 | 1.4 |
Voya SmallCap Opportunities Portfolio | PORTFOLIO OF INVESTMENTS |
as of March 31, 2023 (Unaudited) (Continued) |
Shares | Value | Percentage of Net Assets | |||
COMMON STOCK: (continued) | |||||
Information Technology: (continued) | |||||
88,582 | (1),(2) | indie Semiconductor, Inc. | $ | 934,540 | 0.5 |
49,450 | Kulicke & Soffa Industries, Inc. | 2,605,520 | 1.3 | ||
9,729 | Littelfuse, Inc. | 2,608,248 | 1.4 | ||
16,347 | (1) | Manhattan Associates, Inc. | 2,531,333 | 1.3 | |
23,350 | (1) | MaxLinear, Inc. | 822,154 | 0.4 | |
47,840 | (1) | Onto Innovation, Inc. | 4,204,179 | 2.2 | |
37,056 | (1) | Sprout Social, Inc. | 2,255,969 | 1.2 | |
14,069 | Universal Display Corp. | 2,182,524 | 1.1 | ||
58,624 | (1) | Varonis Systems, Inc. | 1,524,810 | 0.8 | |
125,390 | (1) | Viavi Solutions, Inc. | 1,357,974 | 0.7 | |
37,595,867 | 19.5 | ||||
Materials: 3.3% | |||||
17,321 | Innospec, Inc. | 1,778,347 | 0.9 | ||
87,142 | (1),(2) | Livent Corp. | 1,892,724 | 1.0 | |
92,583 | (1) | Summit Materials, Inc. | 2,637,690 | 1.4 | |
6,308,761 | 3.3 | ||||
Total Common Stock | |||||
(Cost $176,984,053) | 184,677,348 | 95.7 | |||
EXCHANGE-TRADED FUNDS: 1.1% | |||||
27,451 | (1) | SPDR S&P Biotech ETF | 2,092,041 | 1.1 | |
Total Exchange-Traded Funds | |||||
(Cost $2,456,397) | 2,092,041 | 1.1 | |||
Total Long-Term Investments | |||||
(Cost $179,440,450) | 186,769,389 | 96.8 | |||
Principal Amount† | Value | Percentage of Net Assets | |||
SHORT-TERM INVESTMENTS: 7.4% | |||||
Repurchase Agreements: 4.0% | |||||
1,853,467 | (3) | Bank of America Inc., Repurchase Agreement dated 03/31/23, 4.82%, due 04/03/23 (Repurchase Amount $1,854,201, collateralized by various U.S. Government Agency Obligations, 1.500%-3.000%, Market Value plus accrued interest $1,890,536, due 11/01/49-02/01/51) | 1,853,467 | 1.0 | |
339,813 | (3) | Citigroup, Inc., Repurchase Agreement dated 03/31/23, 4.81%, due 04/03/23 (Repurchase Amount $339,947, collateralized by various U.S. Government/U.S. Government Agency Obligations, 1.500%-7.000%, Market Value plus accrued interest $346,609, due 12/26/24-03/20/53) | 339,813 | 0.2 | |
1,853,467 | (3) | HSBC Securities USA, Repurchase Agreement dated 03/31/23, 4.80%, due 04/03/23 (Repurchase Amount $1,854,198, collateralized by various U.S. Government/U.S. Government Agency Obligations, 0.000%-6.500%, Market Value plus accrued interest $1,890,536, due 06/15/24-02/15/53) | 1,853,467 | 0.9 | |
1,853,467 | (3) | Jefferies LLC, Repurchase Agreement dated 03/31/23, 4.91%, due 04/03/23 (Repurchase Amount $1,854,215, collateralized by various U.S. Government Agency Obligations, 0.000%-5.750%, Market Value plus accrued interest $1,890,548, due 04/14/23-03/21/28) | 1,853,467 | 0.9 | |
1,853,467 | (3) | RBC Dominion Securities Inc., Repurchase Agreement dated 03/31/23, 4.82%, due 04/03/23 (Repurchase Amount $1,854,201, collateralized by various U.S. Government/U.S. Government Agency Obligations, 0.000%-6.375%, Market Value plus accrued interest $1,890,536, due 04/06/23-02/20/53) | 1,853,467 | 1.0 | |
Total Repurchase Agreements | |||||
(Cost $7,753,681) | 7,753,681 | 4.0 |
Voya SmallCap Opportunities Portfolio | PORTFOLIO OF INVESTMENTS |
as of March 31, 2023 (Unaudited) (Continued) |
Shares | Value | Percentage of Net Assets | ||||
Mutual Funds: 3.4% | ||||||
6,624,000 | (4) | Morgan Stanley Institutional Liquidity Funds - Government Portfolio (Institutional Share Class), 4.730% | ||||
(Cost $6,624,000) | $ | 6,624,000 | 3.4 | |||
Total Short-Term Investments | ||||||
(Cost $14,377,681) | 14,377,681 | 7.4 | ||||
Total Investments in Securities (Cost $193,818,131) | $ | 201,147,070 | 104.2 | |||
Liabilities in Excess of Other Assets | (8,057,428 | ) | (4.2) | |||
Net Assets | $ | 193,089,642 | 100.0 |
† | Unless otherwise indicated, principal amount is shown in USD. |
ADR | American Depositary Receipt |
(1) | Non-income producing security. |
(2) | Security, or a portion of the security, is on loan. |
(3) | All or a portion of the security represents securities purchased with cash collateral received for securities on loan. |
(4) | Rate shown is the 7-day yield as of March 31, 2023. |
Fair Value Measurements
The following is a summary of the fair valuations according to the inputs used as of March 31, 2023 in valuing the assets and liabilities:
Quoted Prices in Active Markets for Identical Investments (Level 1) | Significant Other Observable Inputs (Level 2) | Significant Unobservable Inputs (Level 3) | Fair Value at March 31, 2023 | |||||||||||||
Asset Table | ||||||||||||||||
Investments, at fair value | ||||||||||||||||
Common Stock* | $ | 184,677,348 | $ | – | $ | – | $ | 184,677,348 | ||||||||
Exchange-Traded Funds | 2,092,041 | – | – | 2,092,041 | ||||||||||||
Short-Term Investments | 6,624,000 | 7,753,681 | – | 14,377,681 | ||||||||||||
Total Investments, at fair value | $ | 193,393,389 | $ | 7,753,681 | $ | – | $ | 201,147,070 |
* | For further breakdown of Common Stock by sector, please refer to the Portfolio of Investments. |
Voya SmallCap Opportunities Portfolio | PORTFOLIO OF INVESTMENTS |
as of March 31, 2023 (Unaudited) (Continued) |
At March 31, 2023, the aggregate cost of securities and other investments and the composition of unrealized appreciation and depreciation of securities and other investments on a tax basis were:
Cost for federal income tax purposes was $196,395,479.
Net unrealized appreciation consisted of:
Gross Unrealized Appreciation | $ | 18,202,908 | ||
Gross Unrealized Depreciation | (13,361,317 | ) | ||
Net Unrealized Appreciation | $ | 4,841,591 |